⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for biliary cancer

Every month we try and update this database with for biliary cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary CancersNCT00626158
Pancreatic Canc...
Biliary Cancer
gemcitabine
capecitabine
18 Years - University of California, San Francisco
Perception Prognosis, Goals of Treatment, and CommunicationNCT01401894
Gastric Cancer
Esophageal Canc...
Pancreatic Canc...
Liver Cancer
Biliary Cancer
18 Years - Massachusetts General Hospital
A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary CarcinomaNCT03609489
Biliary Carcino...
Capecitabine
Apatinib
18 Years - 75 YearsFirst Affiliated Hospital of Guangxi Medical University
Neoadjuvant Therapy in Biliary AdenocarcinomaNCT04480190
Cholangiocarcin...
Biliary Cancer
Gemcitabine
Cisplatin
Fluorouracil
Short course Ch...
18 Years - University of Cincinnati
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid TumorsNCT00551096
Malignant Solid...
Biliary Cancer
Pancreatic Canc...
Gemcitabine
Capecitabine
ZD6474
18 Years - University of Colorado, Denver
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary CancerNCT01773785
Biliary Cancer
SPI-1620
Docetaxel
18 Years - Spectrum Pharmaceuticals, Inc
Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic AlterationsNCT04087876
Intrahepatic Ch...
derazantinib
18 Years - Basilea Pharmaceutica
IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic SpreadNCT01099631
Cancer of the L...
Liver Cancer
Hepatoma
Liver Neoplasms
Biliary Cancer
Salmonella typh...
18 Years - Masonic Cancer Center, University of Minnesota
NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary CancerNCT04005339
Advanced Biliar...
Nanoliposomal I...
Leucovorin
Fluorouracil
18 Years - Georgetown University
Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary CancerNCT02479984
Pancreatic Canc...
Staging Laparos...
Laparoscopic ul...
15 Years - 80 YearsNational Cancer Center, Korea
GTX Regimen for Biliary CancersNCT00868998
Biliary Cancer
Gemcitabine, do...
18 Years - Columbia University
Quality of Life of Patients Over 75 Yars Undergoing Palliative ChemotherapyNCT04517448
Colorectal Canc...
Pancreatic Canc...
Biliary Cancer
Hepatic Cancer
Oesophageal Can...
Gastric Cancer
75 Years - Centre Hospitalier de la côte Basque
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).NCT04566133
Bile Duct Cance...
Biliary Cancer
Biliary Tract N...
Cholangiocarcin...
Trametinib
Hydroxychloroqu...
18 Years - National Institutes of Health Clinical Center (CC)
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesNCT04644068
Ovarian Cancer
Breast Cancer
Pancreatic Canc...
Prostate Cancer
Additional Indi...
Non-small Cell ...
Colorectal Canc...
Bladder Cancer
Gastric Cancer
Biliary Cancer
Cervical Cancer
Endometrial Can...
Small Cell Lung...
AZD5305
Paclitaxel
Carboplatin
T- Dxd
Dato-DXd
Camizestrant
18 Years - 130 YearsAstraZeneca
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsNCT05592626
Advanced Solid ...
Genital Neoplas...
Urogenital Neop...
Lung Neoplasm
Neoplasms by Si...
Papillomavirus ...
Epstein-Barr Vi...
Carcinoma
Neoplasms
Vulvar Neoplasm...
Vulvar Diseases
Abdominal Neopl...
STAR0602
18 Years - Marengo Therapeutics, Inc.
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical ResectionNCT05517811
Liver Cancer
Esophageal Canc...
Colorectal Canc...
Lung Adenocarci...
Control
Pancreas Cancer
Biliary Cancer
TEG indices
18 Years - 99 YearsUniversity of Colorado, Denver
Postoperative Oral Nutritional Supplementation After Major Gastrointestinal SurgeryNCT01838109
Gastric Cancer
Colon Cancer
Pancreatic Canc...
Duodenal Cancer
Biliary Cancer
Peptic Ulcer
Inflammatory Bo...
oral nutritiona...
20 Years - 80 YearsSeoul National University Hospital
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsNCT02576431
Solid Tumors Ha...
BAY2757556 (Lar...
18 Years - Bayer
Covered Versus Uncovered SEMS for Palliation of Malignant Biliary Strictures.NCT02930252
Biliary Cancer
Niti-S Biliary ...
Niti-S stent (D...
18 Years - Azienda USL 1 Imperiese
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)NCT02628067
Advanced Cancer
Anal Carcinoma
Anal Cancer
Biliary Cancer
Cholangiocarcin...
Bile Duct Cance...
Neuroendocrine ...
Carcinoid Tumor
Endometrial Car...
Endometrial Can...
Cervical Carcin...
Cervical Cancer
Vulvar Carcinom...
Vulvar Cancer
Small Cell Lung...
Small Cell Lung...
Mesothelioma
Thyroid Carcino...
Thyroid Cancer
Salivary Gland ...
Salivary Gland ...
Salivary Cancer
Parotid Gland C...
Advanced Solid ...
Colorectal Carc...
pembrolizumab
pembrolizumab
18 Years - Merck Sharp & Dohme LLC
GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract CancerNCT01859728
Biliary Cancer
Irinotecan
Cisplatin
Cisplatin
Gemcitabine
18 Years - Barretos Cancer Hospital
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)NCT02628067
Advanced Cancer
Anal Carcinoma
Anal Cancer
Biliary Cancer
Cholangiocarcin...
Bile Duct Cance...
Neuroendocrine ...
Carcinoid Tumor
Endometrial Car...
Endometrial Can...
Cervical Carcin...
Cervical Cancer
Vulvar Carcinom...
Vulvar Cancer
Small Cell Lung...
Small Cell Lung...
Mesothelioma
Thyroid Carcino...
Thyroid Cancer
Salivary Gland ...
Salivary Gland ...
Salivary Cancer
Parotid Gland C...
Advanced Solid ...
Colorectal Carc...
pembrolizumab
pembrolizumab
18 Years - Merck Sharp & Dohme LLC
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)NCT05849480
Biliary Cancer
Bile Duct Cance...
Cancer of the B...
oxaliplatin
capecitabine
Keytruda
CDX-1140
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract AdenocarcinomaNCT00948935
Biliary Cancer
Cholangiocarcin...
Gemcitabine, Ir...
18 Years - Abramson Cancer Center at Penn Medicine
Tremelimumab With Chemoembolization or Ablation for Liver CancerNCT01853618
Heptocellular C...
Biliary Tract N...
Liver Cancer
Hepatocellular ...
Biliary Cancer
Tremelimumab
RFA
TACE
Cryoablation
18 Years - 99 YearsNational Institutes of Health Clinical Center (CC)
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary CancerNCT02908451
Gastric Cancer
Colorectal Canc...
Pancreatic Canc...
Biliary Cancer
AbGn-107
18 Years - AbGenomics B.V Taiwan Branch
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical ResectionNCT05517811
Liver Cancer
Esophageal Canc...
Colorectal Canc...
Lung Adenocarci...
Control
Pancreas Cancer
Biliary Cancer
TEG indices
18 Years - 99 YearsUniversity of Colorado, Denver
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).NCT04566133
Bile Duct Cance...
Biliary Cancer
Biliary Tract N...
Cholangiocarcin...
Trametinib
Hydroxychloroqu...
18 Years - National Institutes of Health Clinical Center (CC)
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)NCT05849480
Biliary Cancer
Bile Duct Cance...
Cancer of the B...
oxaliplatin
capecitabine
Keytruda
CDX-1140
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid TumorsNCT02091141
Neoplasms
Solid Tumors
Biliary Cancer
Salivary Cancer
Bladder Cancer
Trastuzumab
Pertuzumab
Erlotinib
Vemurafenib
Cobimetinib
Vismodegib
Alectinib
Atezolizumab
18 Years - Genentech, Inc.
Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary CancerNCT02479984
Pancreatic Canc...
Staging Laparos...
Laparoscopic ul...
15 Years - 80 YearsNational Cancer Center, Korea
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)NCT06101277
Esophageal Canc...
Small Bowel Can...
Gastroesophagea...
Gastric Cancer
Colorectal Canc...
Appendiceal Can...
Biliary Cancer
Gall Bladder Ca...
Intrahepatic Ch...
Extrahepatic Ch...
Oligoprogressiv...
Ablative local ...
18 Years - University of California, Davis
A Study of Patients Receiving High-Dose Rate BrachytherapyNCT00924027
Cervical Cancer
Endometrial Can...
Esophageal Canc...
Prostate Cancer
Biliary Cancer
HDR Brachythera...
18 Years - National Institutes of Health Clinical Center (CC)
Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract AdenocarcinomaNCT01375972
Metastatic Bili...
S-1 plus cispla...
Gemcitabine plu...
18 Years - Asan Medical Center
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary CancersNCT00626158
Pancreatic Canc...
Biliary Cancer
gemcitabine
capecitabine
18 Years - University of California, San Francisco
A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary CarcinomaNCT03609489
Biliary Carcino...
Capecitabine
Apatinib
18 Years - 75 YearsFirst Affiliated Hospital of Guangxi Medical University
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)NCT02628067
Advanced Cancer
Anal Carcinoma
Anal Cancer
Biliary Cancer
Cholangiocarcin...
Bile Duct Cance...
Neuroendocrine ...
Carcinoid Tumor
Endometrial Car...
Endometrial Can...
Cervical Carcin...
Cervical Cancer
Vulvar Carcinom...
Vulvar Cancer
Small Cell Lung...
Small Cell Lung...
Mesothelioma
Thyroid Carcino...
Thyroid Cancer
Salivary Gland ...
Salivary Gland ...
Salivary Cancer
Parotid Gland C...
Advanced Solid ...
Colorectal Carc...
pembrolizumab
pembrolizumab
18 Years - Merck Sharp & Dohme LLC
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: